Prostate cancer decisions — 2022

The Veteran's service-connected prostate cancer residuals and erectile dysfunction rendered him unable to secure and follow a substantially gainful occupation consistent with his education and work history prior to August 28, 2020. As such, the Board granted a TDIU for this period.

The Board denied service connection for prostate cancer, glaucoma, and sleep apnea. The Veteran's claims were not supported by evidence showing a direct relationship to his military service or any recognized exposure to herbicides.

The Board has dismissed the appeal for an increased rating for prostate cancer residuals. The appeals for service connection and higher ratings for skin disease, heart disease, lung disease, GERD, PTSD, and erectile dysfunction are remanded.

The Veteran's service connection claims for prostate cancer, diabetes, and hypertension have been granted. However, the claim for hypertension remains pending as it has been remanded.

The Board has remanded the Veteran's claims of service connection for chronic prostate problems and erectile dysfunction due to lack of a VA examination, outstanding private treatment records, and potential 38 U.S.C. § 1151 claim.

The Veteran's claim for a rating in excess of 10 percent for eczema of the bilateral lower extremities was denied, and his claim for TDIU prior to May 21, 2019, was also denied.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran's death was caused by his service-connected tuberculosis or if it contributed significantly to his death.

The Board has remanded the case due to inadequate medical opinions regarding direct service connection for prostate cancer, and a new opinion is needed.

The Board denied service connection for prostate cancer and granted service connection for kidney cancer with an effective date of March 14, 2017. The Veteran also requested an earlier effective date for the grant of service connection for kidney cancer based on direct service connection, but this was not granted as it would be precluded by the liberalizing regulations.

The Veteran's prostate cancer and lymphoma are remanded for further examination to determine their etiology, including exposure to Agent Orange from treating servicemembers returning from Vietnam.

The Board has remanded the claims of service connection for prostate cancer and erectile dysfunction due to exposure to contaminated water at Camp Lejeune. The Veteran's private urologist provided opinions linking his conditions to this exposure, but these opinions are insufficient. A new VA medical opinion is needed to address these deficiencies.

The Board has determined that a timely substantive appeal was not filed with respect to the December 1, 2017 statement of the case regarding service connection for prostate cancer and bladder cancer. The appeal is denied.

The Board has granted service connection for heart condition, prostate cancer, and erectile dysfunction secondary to prostate cancer due to herbicide exposure. Service connection was denied for emphysema pulmonary and bronchiectasis.

The Veteran's claims for service connection for bronchitis, prostate cancer residuals, and urinary incontinence have all been denied. The Board found that the evidence did not support a finding of current disabilities related to service or secondary to service-connected conditions.,Service connection was granted for bilateral shoulder, hip, knee, ankle, and foot disabilities, cervical and lumbar spine disabilities, asthma, and rhinitis in September 2021.

The Board has remanded the Veteran's claims for increased rating and TDIU due to prostate cancer, as well as his claim for bilateral hip, knee, and ankle swelling and pain. The Veteran is seeking a higher rating for his service-connected prostate cancer and also wishes to establish service connection for lower extremity conditions that he believes are related to his prostate surgery.

The Veteran's prostate cancer is granted as service connected due to herbicide exposure during his time in Thailand.

The Board has granted service connection for prostate cancer as due to herbicide exposure, finding that the Veteran was exposed to Agent Orange during his deployment in Korea and resolving reasonable doubt in his favor.

The Board denied the Veteran's claim for an earlier effective date for prostate cancer service connection, finding that the original claim was received on August 4, 2017, and no earlier claims were found. The decision also noted there is no probative medical evidence of prostate cancer prior to July 2017.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran's service-connected disabilities caused or aggravated his obesity, which in turn may have contributed to his prostate cancer. The Veteran and his representative are asked to submit additional medical research from 'John Hopkins Institute'.

The Veteran's jaw disability claim is denied as there is no diagnosed condition.,Prior to June 27, 2022, the low back disability was rated at 10 percent. From June 27, 2022, a 20 percent rating is granted.,The GERD with status post right inguinal hernia repair claim remains pending as there are no compensable ratings assigned prior to June 27, 2022.,Service connection for the left eye disability must be remanded due to lack of a statement of the case (SOC).,Prostate cancer (adjudicated as cramps and pain in the testicles) claim is pending as there are no compensable ratings assigned prior to June 27, 2022.,Service connection for skin disability of the feet and face remains pending due to lack of a statement of the case (SOC).,Heart disability (adjudicated as chest pain) claim must be remanded due to lack of a statement of the case (SOC).,Right carpal tunnel syndrome claim is pending as there are no compensable ratings assigned prior to June 27, 2022.